Emergence of the L phenotype in Group B Streptococci in the South of Ireland

Epidemiol Infect. 2017 Dec;145(16):3535-3542. doi: 10.1017/S0950268817002461. Epub 2017 Nov 6.

Abstract

Group B Streptococcal isolates (n = 235) from the South of Ireland were characterised by serotyping, antimicrobial susceptibility and determination of the phenotypic and genotypic mechanisms of resistance. Resistance to erythromycin and clindamycin was observed in 21·3% and 20·4% of the total population, respectively. The c-MLSB phenotype was the most common phenotype detected (62%), with ermB being the predominant genetic determinant, present in 84% of resistant isolates. The rare L phenotype was observed in 2·9% (n = 7) of isolates, four of which harboured the lsaC gene responsible for clindamycin resistance. Serotypes Ia, III and II were the most common amongst the entire study population (28·1%, 24·7% and 14%, respectively). Four of the seven L phenotype isolates were serotype III and two of these strains were confirmed as the hypervirulent clone, ST-17 and harboured the hvgA gene. This is the first documented case of the L phenotype in Ireland to date and the study findings emphasise the need for continued monitoring of antibiotic resistance and serotype distribution in GBS isolates from Ireland.

Keywords: Microbiology; Streptococcal infections; antibiotic resistance; surveillance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Infant, Newborn
  • Ireland / epidemiology
  • Microbial Sensitivity Tests
  • Middle Aged
  • Prospective Studies
  • Streptococcal Infections* / epidemiology
  • Streptococcal Infections* / microbiology
  • Streptococcus agalactiae* / drug effects
  • Streptococcus agalactiae* / genetics
  • Young Adult

Substances

  • Anti-Bacterial Agents